IKARIAN CAPITAL, LLC purchased 17.5% of their position (322.47K shares) of TRACON PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $1.06M — a significant purchase. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 9/15/2020ACC: 0000899243-20-025195
10% OwnerOther
Since Sep 2020
+322.47K
Net shares
Net buyer
$1.06M
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
322.47K acquired
Non-Derivative Transactions4
Common Stock, par value $0.001 per share
Indirect
Shares
+151.61K
Price / share
$2.87
Trade value
$434.50K
% of position
8.2%
9/4/2020
1.84M→1.99M
Common Stock, par value $0.001 per share
Indirect
Shares
+13.24K
Price / share
$2.90
Trade value
$38.41K
% of position
0.7%
9/8/2020
1.99M→2M
Common Stock, par value $0.001 per share
Indirect
Shares
+79.42K
Price / share
$3.49
Trade value
$277.46K
% of position
4.0%
9/9/2020
2M→2.08M
Common Stock, par value $0.001 per share
Indirect
Shares
+78.20K
Price / share
$3.93
Trade value
$307.02K
% of position
3.8%
9/11/2020
2.08M→2.16M
Total
Net shares
+322.47K
Net value
$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 9/4/2020 | P · Purchase | +151.61K | $2.87 | $434.50K | 8.2% | 1.84M | 1.99M |
| Common Stock, par value $0.001 per share Indirect | 9/8/2020 | P · Purchase | +13.24K | $2.90 | $38.41K | 0.7% | 1.99M | 2M |
| Common Stock, par value $0.001 per share Indirect | 9/9/2020 | P · Purchase | +79.42K | $3.49 | $277.46K | 4.0% | 2M | 2.08M |
| Common Stock, par value $0.001 per share Indirect | 9/11/2020 | P · Purchase | +78.20K | $3.93 | $307.02K | 3.8% | 2.08M | 2.16M |
| Total | +322.47K | $1.06M | ||||||
Derivative Transactions0
No derivative transactions reported